Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00502658 · ClinicalTrials.gov registry record · NA

Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight

A NA study, sponsored by Pharmanex.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT00502658: Completed NA study, sponsored by Pharmanex.

NCT00502658 is a NA study that has completed, run by Pharmanex. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00502658, a NA study, has completed, sponsored by Pharmanex.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

Excessive body weight is becoming a concern around the world, for example over half of the American adult population is overweight or obese. The purpose of this study is to determine whether dietary supplements and shakes containing a combination of nutrients/ingredients individually shown in research studies to reduce hunger, enhance metabolism, reduce the body's ability to 'store' fat, and enhance energy, promote healthy body weight and composition over 12 weeks. A further study objective is to determine whether the inclusion of a personal, easy to use, energy tracking device for the measurement of daily energy intake and expenditure also helps with the promotion of healthy body weight and body composition. In this prospective, blinded study 120 volunteers who meet the entrance criteria including a BMI 25-35 kg/m2 and sign the informed consent form to participate in a 12 week long study will be recruited. All subjects will consume a multi-vitamin, mineral and fish oil supplement. Subjects will be randomly assigned to a control or experimental group and stratified by BMI 25-30 and \>30-35 kg/m2, age, and gender with an equal number of subjects in each strata across groups. A subset of subjects will also wear a personal energy tracking device. Subjects will be instructed how to incorporate the shakes and supplements into their current diet and encouraged to incorporate fruits, vegetables, whole grains, and other healthy foods into their current meals and to exercise at least 30 minutes five days per week.

Interventions

  • BEHAVIORAL Dietary supplement containing vitamins, minerals, and herbs
  • BEHAVIORAL Shakes with nutrients and herbs
  • BEHAVIORAL Control dietary supplement
  • BEHAVIORAL Isocaloric, isonitrogenous control shakes without herbs
  • BEHAVIORAL Personal energy tracking tool

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2007-07
Est. Completion 2007-12
Phase NA
Pharmanex

13 total trials

What the finished NCT00502658 record still lists

NCT00502658 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 5 interventions - of which Dietary supplement containing vitamins, minerals, and herbs is the first listed.

NCT00502658 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00502658 about?

NCT00502658 is a clinical study titled "Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight". Excessive body weight is becoming a concern around the world, for example over half of the American adult population is overweight or obese. The purpose of this study is to determine whether dietary supplements and shakes containing a combination of nutrients/ingredients individually shown in resear...

What is the current status of trial NCT00502658?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2007-07. Estimated completion is 2007-12.

What interventions are being tested in trial NCT00502658?

The interventions under investigation include: Dietary supplement containing vitamins, minerals, and herbs (BEHAVIORAL), Shakes with nutrients and herbs (BEHAVIORAL), Control dietary supplement (BEHAVIORAL), Isocaloric, isonitrogenous control shakes without herbs (BEHAVIORAL), Personal energy tracking tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT00502658?

This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00502658's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00502658, the US trial registry maintained by the National Library of Medicine. NCT00502658 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.